Filing Details

Accession Number:
0000899243-22-038529
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-14 21:22:15
Reporting Period:
2022-12-14
Accepted Time:
2022-12-14 21:22:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796129 Vincerx Pharma Inc. VINC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1458506 Md Ahmed Hamdy 260 Sheridan Avenue, Suite 400
Palo Alto CA 94306
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-14 35,280 $0.87 73,760 No 4 P Indirect The Hamdy Family Trust dated 10/7/2015
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect The Hamdy Family Trust dated 10/7/2015
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,618,199 Direct
Footnotes
  1. Represents a weighted average purchase price. Actual purchase prices ranged from $0.829 to $0.87 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.